Market closedNon-fractional

Sophia Genetics/SOPH

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Sophia Genetics

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Ticker

SOPH

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Technology

Headquarters

Rolle, Switzerland

Employees

430

Sophia Genetics Metrics

BasicAdvanced
$301M
Market cap
-
P/E ratio
-$1.12
EPS
1.12
Beta
-
Dividend rate
$301M
1.12
4.144
3.796
11.146
13.19
-126.30%
-22.52%
-46.03%
4.66
2.29
2.86
-5.239
26.68%
-11.77%
29.01%
6.61%

What the Analysts think about Sophia Genetics

Analyst Ratings

Majority rating from 4 analysts.
Buy

Sophia Genetics Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-87.26% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$16M
-7.65%
Net income
-$14M
-42.92%
Profit margin
-87.26%
-38.19%

Sophia Genetics Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 23.17%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.33
-$0.21
-$0.37
-$0.21
-
Expected
-$0.31
-$0.32
-$0.27
-$0.27
-$0.27
Surprise
7.70%
-35.05%
37.04%
-23.17%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Sophia Genetics stock?

Sophia Genetics (SOPH) has a market cap of $301M as of July 06, 2024.

What is the P/E ratio for Sophia Genetics stock?

The price to earnings (P/E) ratio for Sophia Genetics (SOPH) stock is 0 as of July 06, 2024.

Does Sophia Genetics stock pay dividends?

No, Sophia Genetics (SOPH) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Sophia Genetics dividend payment date?

Sophia Genetics (SOPH) stock does not pay dividends to its shareholders.

What is the beta indicator for Sophia Genetics?

Sophia Genetics (SOPH) has a beta rating of 1.12. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Sophia Genetics stock

Buy or sell Sophia Genetics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing